Kanai O[au] - Search Results - PubMed - 188bet官网地址,188bet体育备用网址,188bet手机版188bet手机版

Year	Number of Results
1951	3
1952	1
1971	1
1973	1
1974	1
1982	1
2013	1
2016	2
2017	3
2018	5
2019	4
2020	11
2021	5

1

Impact of COVID-19 pandemic on lung cancer treatment scheduling.

Fujita K, Ito T, Saito Z,Kanai O, Nakatani K, Mio T. Fujita K, et al. Among authors:kanai o. Thorac Cancer. 2020 Oct;11(10):2983-2986. doi: 10.1111/1759-7714.13615. Epub 2020 Aug 12. Thorac Cancer. 2020. PMID:32790028 Free PMC article.

2

Retreatment With Anti-PD-L1 Antibody in Advanced Non-small Cell Lung Cancer Previously Treated With Anti-PD-1 Antibodies.

Fujita K, Uchida N, Yamamoto Y,Kanai O, Okamura M, Nakatani K, Sawai S, Mio T. Fujita K, et al. Among authors:kanai o. Anticancer Res. 2019 Jul;39(7):3917-3921. doi: 10.21873/anticanres.13543. Anticancer Res. 2019. PMID:31262921

3

Real-world effectiveness and safety of nivolumab in patients with non-small cell lung cancer: A multicenter retrospective observational study in Japan.

Morita R, Okishio K, Shimizu J, Saito H, Sakai H, Kim YH, Hataji O, Yomota M, Nishio M, Aoe K,Kanai O, Kumagai T, Kibata K, Tsukamoto H, Oizumi S, Fujimoto D, Tanaka H, Mizuno K, Masuda T, Kozuki T, Haku T, Suzuki H, Okamoto I, Hoshiyama H, Ueda J, Ohe Y. Morita R, et al. Among authors:kanai o. Lung Cancer. 2020 Feb;140:8-18. doi: 10.1016/j.lungcan.2019.11.014. Epub 2019 Nov 20. Lung Cancer. 2020. PMID:31838169 Free article.

4

Efficacy and safety of nivolumab in non-small cell lung cancer with preexisting interstitial lung disease.

Kanai O, Kim YH, Demura Y, Kanai M, Ito T, Fujita K, Yoshida H, Akai M, Mio T, Hirai T. Kanai O, et al. Thorac Cancer. 2018 Jul;9(7):847-855. doi: 10.1111/1759-7714.12759. Epub 2018 May 21. Thorac Cancer. 2018. PMID:29782069 Free PMC article.

5

Retreatment with anti-PD-1 antibody in non-small cell lung cancer patients previously treated with anti-PD-L1 antibody.

Fujita K, Yamamoto Y,Kanai O, Okamura M, Hashimoto M, Nakatani K, Sawai S, Mio T. Fujita K, et al. Among authors:kanai o. Thorac Cancer. 2020 Jan;11(1):15-18. doi: 10.1111/1759-7714.13241. Epub 2019 Nov 7. Thorac Cancer. 2020. PMID:31701630 Free PMC article.

6

再处理先进non-sma pembrolizumabll cell lung cancer patients previously treated with nivolumab: emerging reports of 12 cases.

Fujita K, Uchida N,Kanai O, Okamura M, Nakatani K, Mio T. Fujita K, et al. Among authors:kanai o. Cancer Chemother Pharmacol. 2018 Jun;81(6):1105-1109. doi: 10.1007/s00280-018-3585-9. Epub 2018 Apr 19. Cancer Chemother Pharmacol. 2018. PMID:29675747

7

Incidence of Active Tuberculosis in Lung Cancer Patients Receiving Immune Checkpoint Inhibitors.

Fujita K, Yamamoto Y,Kanai O, Okamura M, Hashimoto M, Nakatani K, Sawai S, Mio T. Fujita K, et al. Among authors:kanai o. Open Forum Infect Dis. 2020 Apr 9;7(5):ofaa126. doi: 10.1093/ofid/ofaa126. eCollection 2020 May. Open Forum Infect Dis. 2020. PMID:32391404 Free PMC article.

8

Single-center analysis of antiresorptive agent-related osteonecrosis of the jaw in lung cancer patients.

Okamura M, Fujita K, Yamamoto Y,Kanai OHorimoto Nakatani K, K,桥本M, Sawai年代,Shimosato M, Yoshida K, Mio T. Okamura M, et al. Among authors:kanai o. Asia Pac J Clin Oncol. 2020 Dec;16(6):380-384. doi: 10.1111/ajco.13395. Epub 2020 Sep 7. Asia Pac J Clin Oncol. 2020. PMID:32893984

9

Development ofMycobacterium aviumComplex Lung Disease in Patients With Lung Cancer on Immune Checkpoint Inhibitors.

Fujita K, Yamamoto Y,Kanai O, Okamura M, Nakatani K, Mio T. Fujita K, et al. Among authors:kanai o. Open Forum Infect Dis. 2020 Mar 7;7(3):ofaa067. doi: 10.1093/ofid/ofaa067. eCollection 2020 Mar. Open Forum Infect Dis. 2020. PMID:32190712 Free PMC article.

10

Sleep disordered breathing and metabolic comorbidities across sex and menopausal status in East Asians: the Nagahama Study.

Matsumoto T, Murase K, Tabara Y, Minami T,Kanai O, Takeyama H, Takahashi N, Hamada S, Tanizawa K, Wakamura T, Komenami N, Setoh K, Kawaguchi T, Tsutsumi T, Morita S, Takahashi Y, Nakayama T, Hirai T, Matsuda F, Chin K. Matsumoto T, et al. Among authors:kanai o. Eur Respir J. 2020 Aug 20;56(2):1902251. doi: 10.1183/13993003.02251-2019. Print 2020 Aug. Eur Respir J. 2020. PMID:32409572

保存citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

搜索页面

Search Results